Immunochemistry multiplex for solid tumor analytical validation,In this interview, NewsMedical exchanges with Cerba on...
immuno oncology
Roche, Exelixis' Tecentriq-Cabometyx pair fails again—this time in kidney cancer,For a new phase 3...
3 Questions: Cullen Buie on a new era for cell therapies,Genetic engineering and personalized...
